Mineralys Therapeutics, Inc. (MLYS) Tops Q1 EPS by 34c

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) reported Q1 EPS of ($0.47), $0.34 better than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Mineralys Therapeutics, Inc. (MLYS) click here.

You May Also Be Interested In

• US Eyes 7.5% China Overcapacity Tariffs Before Xi-Trump Talks - Bloomberg
• XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
• Palo Alto Networks (PANW) PT Raised to $400 at Benchmark Ahead of Q4 Earnings